Capital Performance Advisors LLP Incyte Corp Transaction History
Capital Performance Advisors LLP
- $504 Million
- Q2 2025
A detailed history of Capital Performance Advisors LLP transactions in Incyte Corp stock. As of the latest transaction made, Capital Performance Advisors LLP holds 4,117 shares of INCY stock, worth $348,833. This represents 0.06% of its overall portfolio holdings.
Number of Shares
4,117
Previous 5,079
18.94%
Holding current value
$348,833
Previous $307,000
8.79%
% of portfolio
0.06%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding INCY
# of Institutions
733Shares Held
202MCall Options Held
516KPut Options Held
265K-
Baker Bros. Advisors LP New York, NY30.7MShares$2.6 Billion21.22% of portfolio
-
Black Rock Inc. New York, NY21.4MShares$1.81 Billion0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA20.1MShares$1.71 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA14.6MShares$1.24 Billion0.6% of portfolio
-
State Street Corp Boston, MA9.88MShares$837 Million0.03% of portfolio
About INCYTE CORP
- Ticker INCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 222,431,008
- Market Cap $18.8B
- Description
- Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...